These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18703938)

  • 1. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
    Nosè M; Tansella M; Thornicroft G; Schene A; Becker T; Veronese A; Leese M; Koeter M; Angermeyer M; Barbui C
    Int Clin Psychopharmacol; 2008 Sep; 23(5):287-90. PubMed ID: 18703938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Defined Daily Dose, percentage of British National Formulary maximum and chlorpromazine equivalents in antipsychotic drug utilization.
    Sweileh WM; Odeh JB; Shraim NY; Zyoud SH; Sawalha AF; Al-Jabi SW
    Saudi Pharm J; 2014 Apr; 22(2):127-32. PubMed ID: 24648824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?
    Rijcken CA; Monster TB; Brouwers JR; de Jong-van den Berg LT
    J Clin Psychopharmacol; 2003 Dec; 23(6):657-9. PubMed ID: 14624195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan.
    Uchida H; Suzuki T; Mamo DC; Mulsant BH; Tanabe A; Inagaki A; Watanabe K; Yagi G; Tomita M
    Am J Geriatr Psychiatry; 2008 Jul; 16(7):584-93. PubMed ID: 18591578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on neuroleptic use in acutely psychotic patients.
    Kirkpatrick B; Burnett GB
    J Clin Psychopharmacol; 1982 Jun; 2(3):205-7. PubMed ID: 6124559
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of antipsychotic drug-defined daily doses versus chlorpromazine equivalent doses in patients with or without extrapyramidal motor symptoms.
    Barr AM; Honer WG; Johnson JL; Wu TK; Procyshyn RM
    J Clin Psychopharmacol; 2010 Dec; 30(6):741-3. PubMed ID: 21057241
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse reactions to chlorpromazine in psychiatric patients.
    Swett C
    Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antipsychotic medications in Australia between July 1995 and December 2001.
    Mond J; Morice R; Owen C; Korten A
    Aust N Z J Psychiatry; 2003 Feb; 37(1):55-61. PubMed ID: 12534657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
    Aparasu RR; Jano E; Johnson ML; Chen H
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
    Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
    Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic comparisons of antipsychotic use in schizophrenia.
    Wheeler A; Humberstone V; Robinson E
    Aust N Z J Psychiatry; 2008 Oct; 42(10):863-73. PubMed ID: 18777230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
    Taylor DM; Smith L
    Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, correlates, and disease patterns of antipsychotic use in Taiwan.
    Chien IC; Hsu JH; Bih SH; Lin CH; Chou YJ; Lee CH; Chou P
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):677-84. PubMed ID: 19068004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of treatment of psychoses with once-a-day phenothiazine doses].
    Sidorowicz S; Krakiewicz A; Wilska M
    Psychiatr Pol; 1979; 13(3):251-6. PubMed ID: 38469
    [No Abstract]   [Full Text] [Related]  

  • 18. Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.
    Bollini P; Pampallona S; Orza MJ; Adams ME; Chalmers TC
    Psychol Med; 1994 May; 24(2):307-16. PubMed ID: 7916157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Violence and Antipsychotic Dosage in Schizophrenia: A Secondary Analysis of The Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE) Dataset.
    Tasmim S; Kolla NJ; Dada O; Bani-Fatemi A; De Luca V
    Pharmacopsychiatry; 2019 Sep; 52(5):217-221. PubMed ID: 30669162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose Equivalents for Antipsychotic Drugs: The DDD Method.
    Leucht S; Samara M; Heres S; Davis JM
    Schizophr Bull; 2016 Jul; 42 Suppl 1(Suppl 1):S90-4. PubMed ID: 27460622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.